Thyroid dysfunction and risk of cutaneous malignant melanoma: a bidirectional two-sample Mendelian randomization study

被引:2
|
作者
Dong, Hua [1 ]
Pan, Lei [2 ]
Shen, Yanhui [3 ]
Xu, Qinxuan [2 ]
Hu, Jinyu [2 ]
Hu, Zhiwei [1 ]
Fei, Yuchang [4 ]
机构
[1] Jiaxing Univ, Jiashan Hosp Affiliated, Peoples Hosp Jiashan 1, Endocrinol Dept, Jiaxing, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[3] Inst Food Drug & Prod Qual Control Jiaxing, Dept Tradit Chinese Med, Jiaxing, Zhejiang, Peoples R China
[4] Jiaxing Univ, Jiashan Hosp affiliated, Peoples Hosp Jiashan 1, Dept Integrated Chinese & Western Med, Jiaxing, Zhejiang, Peoples R China
来源
关键词
thyroid dysfunction; hypothyroidism; hyperthyroidism; cutaneous malignant melanoma (CMM); Mendelian randomization study; BREAST-CANCER; HORMONE; EPIDEMIOLOGY; POPULATION; DIAGNOSIS; DISEASE; AXIS;
D O I
10.3389/fendo.2023.1239883
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Epidemiologic and observational data have found a risk association between thyroid dysfunction and cutaneous malignant melanoma (CMM), however, the cause and direction of these effects are yet unknown. By using a bidirectional two-sample Mendelian randomization (MR) methodology, we hoped to further investigate the causal link between thyroid dysfunction and CMM in this work. Methods: A genome-wide association study (GWAS) of 9,851,867 single nucleotide polymorphisms (SNPs) in a European population was used to develop genetic tools for thyroid dysfunction. Hypothyroidism was linked to 22,687 cases and 440,246 controls. For hyperthyroidism, there were 3545 cases and 459,388 controls. A total of 3751 cases and 372016 controls were included in the genetic data for CMM from UK Biobank (http://www.nealelab.is/uk-biobank) (the Dataset: ieu -b -4969). Among them, inverse variance weighting (IVW) is the main MR Analysis method for causality assessment. MR-Egger method, MR Pleiotropic residual and outlier test (MR-PRESSO), and simple and weighted median (VM) were used to supplement the IVW method. Sensitivity analyses, mainly Cochran's Q test, leave-one-out analysis, and MR Egger intercept test were performed to assess the robustness of the outcomes. Results: The two-sample MR Analysis results revealed a negative correlation between genetically predicted hypothyroidism and the probability of CMM (OR=0.987, 95%CI =0.075-0.999, p=0.041). The supplemental MR Analysis did not reveal any statistically significant differences, although the direction of the effect sizes for the other approaches was consistent with the IVW effect sizes. The results of the causal analysis were relatively robust, according to a sensitivity analysis. The risk of CMM was unaffected by hyperthyroidism (p>0.05). No correlation between CMM and thyroid dysfunction was seen in the reverse MR analysis. Conclusion: Although the magnitude of the causal association is weak and further investigation of the mechanism of this putative causal relationship is required, our findings imply that hypothyroidism may be a protective factor for CMM.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Are cathepsins a risk factor for papillary thyroid carcinoma? A bidirectional two-sample mendelian randomization analysis
    Sun, Zhen
    Chen, Huarong
    Li, Changya
    Yang, Hao
    Ling, Junjun
    Chang, Aoshuang
    Zhao, Houyu
    Zhuo, Xianlu
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2025,
  • [12] Multiple thyroid disorders and risk of osteoporosis: a two-sample Mendelian randomization study
    Shi, Guang
    Lin, Zhao
    Shen, Qixiao
    Jin, Wei
    Hao, Zhuowen
    Wang, Junwu
    Chen, Tianhong
    Chen, Jiayao
    Wang, Xin
    Li, Jingfeng
    JOURNAL OF BONE AND MINERAL METABOLISM, 2025, 43 (02) : 96 - 107
  • [13] PLATELET TRAITS AND SEPSIS RISK AND PROGNOSIS: A BIDIRECTIONAL TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY
    Song, Zhonghai
    Li, Hua
    Zhang, Jing
    Huang, Yaomeng
    Gao, Shichao
    SHOCK, 2025, 63 (04): : 520 - 526
  • [14] Causal association between thyroid dysfunction and sepsis: a two-sample mendelian randomization study
    Hong, Junbin
    Zhang, Lian
    Lai, Yanni
    Chen, Xinying
    Chen, Yiting
    Yang, Jinghua
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [15] Thyroid function and epilepsy: a two-sample Mendelian randomization study
    Lu, Di
    Wang, Yunming
    Yang, Yanfeng
    Zhang, Huaqiang
    Fan, Xiaotong
    Chen, Sichang
    Wei, Penghu
    Shan, Yongzhi
    Zhao, Guoguang
    FRONTIERS IN HUMAN NEUROSCIENCE, 2024, 17
  • [16] Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study
    Yang, Mingyi
    Su, Yani
    Xu, Ke
    Xie, Jiale
    Wen, Pengfei
    Liu, Lin
    Yang, Zhi
    Xu, Peng
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [17] Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study
    Mingyi Yang
    Yani Su
    Ke Xu
    Jiale Xie
    Pengfei Wen
    Lin Liu
    Zhi Yang
    Peng Xu
    Arthritis Research & Therapy, 25
  • [18] Iron Status, Thyroid Dysfunction, and Iron Deficiency Anemia: A Two-Sample Mendelian Randomization Study
    Huang, Xianjun
    Mao, Mingqiu
    Guo, Tianhong
    Wu, Yuqin
    Xu, Qi
    Dai, Junliang
    Huang, Yuanshuai
    ANNALS OF NUTRITION AND METABOLISM, 2024, 80 (06) : 295 - 306
  • [19] Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study
    Wang, Zheng
    Wang, Yunyun
    Xiong, Jiachao
    Gan, Xinxin
    Bao, Yewei
    Jiang, Aimin
    Zhou, Ye
    Zhao, Huangfu
    Yang, Yiren
    Liu, Zhiyong
    Xia, Demeng
    Wang, Linhui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [20] Causal relationship between thyroid dysfunction and hallux valgus: A two-sample Mendelian randomization study
    Xiong, Binglang
    Bai, Zixing
    Cao, Xuhan
    Nie, Duorui
    Zhang, Cheng
    Sun, Xudong
    Guo, Ziyan
    Wen, Jianmin
    Sun, Weidong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14